UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
Specialized Health Products International, Inc.
------------------------------------------------
(Name of Issuer)
Common Stock
------------------------------
(Title of Class of Securities)
847461100
---------------------
(CUSIP Number)
Check the following box if a fee is being paid with
this statement [X]. (A fee is not required only if the
filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five
percent of the class of securities described in Item
1; and (2) has filed no amendment subsequent thereto
reporting beneficial ownership of five percent or less
of such class.) (See Rule 13d-7).
*The remainder of this cover page shall be filled out
for a reporting person's initial filing on this form
with respect to the subject class of securities, and
for any subsequent amendment containing information
which would alter the disclosures provided in a prior
cover page.
The information required in the remainder of this
cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act
of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however,
see the Notes).
13G
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
David A. Robinson
###-##-####
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
(b)
3 SEC USE ONLY
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF 5 SOLE VOTING POWER
SHARES 630,219
BENEFICIALLY
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING
PERSON 7 SOLE DISPOSITIVE POWER
WITH 630,219
8 SHARED DISPOSITIVE POWER
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
630,219
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES*
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.1%
12 TYPE OF REPORTING PERSON*
IN
Item 1.
(a) Name of Issuer:
Specialized Health Products International, Inc.
(b) Address of Issuer's Principal Executive Offices:
655 East Medical Drive, Bountiful, Utah 84010
Item 2.
(a) Name of Filing Person: David A. Robinson
(b) Address of Principal Business Office or, if None,
Residence: 2453 S. Wood Hollow Way,
Bountiful, Utah 84010
(c) Citizenship: United States of America
(d) Title of Class of Securities: Common Stock
(e) CUSIP No.: 847461100
Item 3.
If This Statement Is Filed Pursuant to Rules 13d-1(b),
or 13d-2(b), Check whether the Person Filing is a:
Not applicable
Item 4.
(a) Amount Beneficially Owned: 630,219 shares
(b) Percent of Class: 7.1%
(c) Number of Shares to Which Such Person Has:
(i) Sole Voting Power of 630,219 shares
(ii) Not applicable
(iii)Sole power to dispose or to direct the
disposition of 630,219 shares
(iv) Not applicable
Item 5.
Ownership of Five Percent or less of a Class: Not
applicable
Item 6.
Ownership of More Than Five Percent on Behalf of
Another Person: Not applicable
Item 7.
Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the
Parent Holding Company: Not applicable
Item 8.
Identification and Classification of Members of the
Group: Not applicable.
Item 9.
Notice of Dissolution of Group: Note applicable.
Item 10.
Certification: By signing below I certify that,
to the best of my knowledge and belief, the securities
referred to above were acquired in the ordinary course
of business and were not acquired for the purpose of
and do not have the effect of changing or influencing
the control of the issuer of such securities and were
not acquired in connection with or as a participant in
any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information
set forth in this statement is true, complete and
correct.
2/13/96
----------------
Date
/s/ David A. Robinson
-------------------------
Signature
David A. Robinson, President
---------------------------------
Name/Title